Quanterix Corp (QTRX) - Net Assets
Based on the latest financial reports, Quanterix Corp (QTRX) has net assets worth $314.53 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($444.14 Million) and total liabilities ($129.61 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Quanterix Corp liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $314.53 Million |
| % of Total Assets | 70.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | 60.12% |
| 10-Year Change | N/A |
| Growth Volatility | 137.21 |
Quanterix Corp - Net Assets Trend (2015–2024)
This chart illustrates how Quanterix Corp's net assets have evolved over time, based on quarterly financial data. Also explore QTRX current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Quanterix Corp (2015–2024)
The table below shows the annual net assets of Quanterix Corp from 2015 to 2024. For live valuation and market cap data, see QTRX company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $330.04 Million | -5.69% |
| 2023-12-31 | $349.96 Million | -2.23% |
| 2022-12-31 | $357.93 Million | -18.83% |
| 2021-12-31 | $440.95 Million | +113.92% |
| 2020-12-31 | $206.12 Million | +60.21% |
| 2019-12-31 | $128.66 Million | +209.60% |
| 2018-12-31 | $41.56 Million | -36.91% |
| 2017-12-31 | $65.87 Million | +388.77% |
| 2016-12-31 | $13.48 Million | +188.69% |
| 2015-12-31 | $-15.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Quanterix Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 38143900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $39.00K | 0.01% |
| Other Comprehensive Income | $-3.08 Million | -0.93% |
| Other Components | $803.16 Million | 243.35% |
| Total Equity | $330.04 Million | 100.00% |
Quanterix Corp Competitors by Market Cap
The table below lists competitors of Quanterix Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lindsay Australia Ltd
AU:LAU
|
$158.86 Million |
|
Samhwa Paint
KO:000390
|
$158.92 Million |
|
Comstock Holding Companies Inc
NASDAQ:CHCI
|
$158.95 Million |
|
Axactor SE
OL:ACR
|
$158.97 Million |
|
Woongjin Co Ltd
KO:016880
|
$158.79 Million |
|
Hyloris Developmentsen Sa
BR:HYL
|
$158.77 Million |
|
Quipt Home Medical Corp
NASDAQ:QIPT
|
$158.74 Million |
|
KEYEAST.Co.Ltd
KQ:054780
|
$158.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Quanterix Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 349,958,000 to 330,038,000, a change of -19,920,000 (-5.7%).
- Net loss of 38,531,000 reduced equity.
- Other comprehensive income decreased equity by 1,408,000.
- Other factors increased equity by 20,019,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-38.53 Million | -11.67% |
| Other Comprehensive Income | $-1.41 Million | -0.43% |
| Other Changes | $20.02 Million | +6.07% |
| Total Change | $- | -5.69% |
Book Value vs Market Value Analysis
This analysis compares Quanterix Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.40x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $-0.94 | $3.40 | x |
| 2016-12-31 | $0.83 | $3.40 | x |
| 2017-12-31 | $3.03 | $3.40 | x |
| 2018-12-31 | $1.86 | $3.40 | x |
| 2019-12-31 | $5.13 | $3.40 | x |
| 2020-12-31 | $6.97 | $3.40 | x |
| 2021-12-31 | $12.25 | $3.40 | x |
| 2022-12-31 | $9.68 | $3.40 | x |
| 2023-12-31 | $9.31 | $3.40 | x |
| 2024-12-31 | $8.60 | $3.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Quanterix Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -11.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.45%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 1.23x
- Recent ROE (-11.67%) is above the historical average (-39.54%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | -130.89% | 1.66x | 0.00x | $-14.42 Million |
| 2016 | -171.96% | -131.78% | 0.47x | 2.75x | $-24.52 Million |
| 2017 | -41.02% | -118.12% | 0.25x | 1.39x | $-33.61 Million |
| 2018 | -74.71% | -82.50% | 0.56x | 1.63x | $-35.20 Million |
| 2019 | -31.71% | -71.91% | 0.33x | 1.32x | $-53.66 Million |
| 2020 | -15.30% | -36.50% | 0.32x | 1.31x | $-52.14 Million |
| 2021 | -13.08% | -52.18% | 0.22x | 1.15x | $-101.78 Million |
| 2022 | -27.82% | -94.36% | 0.24x | 1.21x | $-135.37 Million |
| 2023 | -8.10% | -23.41% | 0.28x | 1.22x | $-63.35 Million |
| 2024 | -11.67% | -28.45% | 0.33x | 1.23x | $-71.53 Million |
Industry Comparison
This section compares Quanterix Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Quanterix Corp (QTRX) | $314.53 Million | 0.00% | 0.41x | $158.82 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa … Read more